Application of a PCSK9 inhibitor in the treatment of lipid disorders – a comprehensive literature

Application of a PCSK9 inhibitor in the treatment of lipid disorders – a comprehensive literature

Lipid disorders stem from imbalances in the levels of cholesterol, low-density lipoproteins (LDL), high-density lipoproteins (HDL), and triglycerides (TG). Among Polish adults over the age of 18, these conditions may affect as many as 60–80% of individuals. Such high prevalence is closely linked to...

Full description

Saved in:
Bibliographic Details
Main Authors: Piotr Rzyczniok, Aneta Rasińska, Weronika Rasińska, Anna Rzyczniok, Justyna Matusik, Natalia Pasierb, Sebastian Kupisiak, Aneta Rostkowska, Paulina Bala, Anna Rebizak, Justyna Jachimczak
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2025-05-01
Series:Quality in Sport
Subjects:
PCSK9 inhibitors
statins
LDL-C
HDL-C
TG
cardiovascular disease
Online Access:https://apcz.umk.pl/QS/article/view/59955
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://apcz.umk.pl/QS/article/view/59955

Similar Items